Evidence map›Paper›PMID 40091113›Full record

ArticleEJNMMI reports2025

Supraclavicular nodal metastasis at primary staging of prostate cancer using

Samuel Nguku Gitau, Jasmit Shah, William Olwit, Samnakay Saeed, Manel Haj Mansour, Khalid Makhdomi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samuel Nguku GitauDepartment of Radiology, Nuclear Medicine Section, Aga Khan University Hospital, Nairobi, Kenya. samuel.gitau@aku.edu.ORCID http://orcid.org/0000-0002-8908-4735
Jasmit ShahBrain and Mind Institute and Department of Medicine, Aga Khan University, Nairobi, Kenya.
William OlwitDepartment of Radiology, Nuclear Medicine Section, Aga Khan University Hospital, Nairobi, Kenya.
Samnakay SaeedDepartment of Urological Surgery, Aga Khan University Hospital, Nairobi, Kenya.
Manel Haj MansourDepartment of Hematology and Oncology, Aga Khan University Hospital, Nairobi, Kenya.
Khalid MakhdomiDepartment of Radiology, Nuclear Medicine Section, Aga Khan University Hospital, Nairobi, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe most common sites of metastasis in prostate cancer are bone, pelvic and retroperitoneal lymph nodes, liver and lungs. This study aimed to evaluate the prevalence of supraclavicular nodal metastasis in newly diagnosed prostate cancer using

methods

resultsA total of 240 patients with prostate cancer staged with

conclusionThere is moderate prevalence of supraclavicular nodal metastasis in patients with intermediate to very high-risk prostate cancer which has likely previously been underdiagnosed with conventional imaging and has been brought to the fore with new-generation imaging such as PSMA PET/CT. It should therefore be an area of consideration during diagnostic work up and follow up of prostate cancer patients. The prognostic significance of supraclavicular nodal metastasis in prostate cancer requires further research.

Indexed as

18F-PSMA PET/CTProstate cancerSC nodalSupraclavicular nodal metastasis

Identifiers

PMID40091113
PMCPMC11911278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.